BCL2 and ovarian carcinoma: Yang et al. (2019) in a study on the resistance of ovarian cancer cells to a platinum drug targeting the BCL2 gene stated that Bcl2 is one of the genes regulating apoptosis in response to DNA damage caused by platinum therapy, which does this by regulating genes such as BAX and BAK [20].